NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Evaluation of antimotion sickness drug side effects on performanceThe effects of antimotion-sickness drugs on the performance in computerized-pursuit-meter tests of groups of ten 18-30-yr-old male and female subjects are investigated experimentally using double-blind placebo techniques. The results are presented in tables and graphs and discussed in detail. The proficiency scores are as good as or better than placebo values for subjects given d-amphetamine (DA) 5 or 10 mg, promethazine (P) 25 mg + scopolamine (S) 400 ng + DA 10 mg, S 1 mg + DA 10 mg, S 250-600 ng, marezine 50 mg, meclizine 50 mg, dimenhydrinate 50 mg, S 1 mg + DA 5 mg, or P 25 mg + DA 10 mg. Significantly lower scores are seen in subjects given S 800 ng or 1 mg, P 25 mg (oral or IM), P 25 mg + S 400 ng, and P 25 mg oral + P 25 mg IM + DA 10 mg.
Document ID
19850059903
Acquisition Source
Legacy CDMS
Document Type
Reprint (Version printed in journal)
Authors
Wood, C. D.
(Louisiana State Univ. Shreveport, LA, United States)
Manno, J. E.
(Louisiana State Univ. Shreveport, LA, United States)
Manno, B. R.
(Louisiana State Univ. Shreveport, LA, United States)
Redetzki, H. M.
(Louisiana State Univ. Shreveport, LA, United States)
Wood, M. J.
(Louisiana, State University Shreveport, United States)
Date Acquired
August 12, 2013
Publication Date
April 1, 1985
Publication Information
Publication: Aviation, Space, and Environmental Medicine
Volume: 56
ISSN: 0095-6562
Subject Category
Aerospace Medicine
Accession Number
85A42054
Funding Number(s)
CONTRACT_GRANT: NAS9-16801
Distribution Limits
Public
Copyright
Other

Available Downloads

There are no available downloads for this record.
No Preview Available